Xilio Therapeutics's total assets for Q4 2024 were $71.08M, a decrease of -4.80% from the previous quarter. XLO total liabilities were $53.48M for the fiscal quarter, a -0.39% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.